These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2884128)

  • 1. [Characteristics of the presynaptic action of harman and its derivatives compared to benzodiazepine tranquilizers].
    Dolzhenko AT; Komissarov IV
    Farmakol Toksikol; 1987; 50(2):13-6. PubMed ID: 2884128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GABA-ergic effects of harman independent of its influence on benzodiazepine receptors].
    Dolzhenko AT; Komissarov IV
    Biull Eksp Biol Med; 1984 Oct; 98(10):446-8. PubMed ID: 6093910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ion-dependency of the GABA-potentiating effects of benzodiazepine tranquilizers and harmane].
    Abramets II; Komissarov IV
    Biull Eksp Biol Med; 1984 Jun; 97(6):679-81. PubMed ID: 6146359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain.
    Schlicker E; Reimann W; Göthert M
    Arzneimittelforschung; 1985; 35(9):1347-9. PubMed ID: 4084337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Harman and its derivatives as potential atypical antidepressants].
    Abramets II; Dolzhenko AT
    Farmakol Toksikol; 1986; 49(4):15-9. PubMed ID: 3758321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The presynaptic metabolic modulation of the impulse-dependent release of 3H-serotonin from rat brain slices by ipsapirone (TVX Q 7821) and other serotonin agonists].
    Dolzhenko AT; Traber J; Glaser T; De Vry J
    Eksp Klin Farmakol; 1993; 56(4):9-12. PubMed ID: 8106062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo.
    Rommelspacher H; Nanz C; Borbe HO; Fehske KJ; Müller WE; Wollert U
    Eur J Pharmacol; 1981 Mar; 70(3):409-16. PubMed ID: 6112154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.
    Jackisch R; Huang HY; Reimann W; Limberger N
    J Pharmacol Exp Ther; 1993 Feb; 264(2):889-98. PubMed ID: 8094757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies on GABA release.
    Schacht U; Bäcker G
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):25S-31S. PubMed ID: 35201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of GABA-potentiating effect of harman].
    Komissarov IV; Abramets II
    Biull Eksp Biol Med; 1982 Oct; 94(10):61-3. PubMed ID: 6293612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 5-(3-[4-(4-fluorophenyl)-1-piperazinyl]-propoxy)indan (BP-528) on benzodiazepine receptor bindings and gamma-aminobutyric acid release.
    Ohta A; Baba A; Iwata H
    Jpn J Pharmacol; 1987 Aug; 44(4):493-7. PubMed ID: 2890781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Harman and 3-methylharman--blockaders of presynaptic alpha 2-adrenoreceptors].
    Dolzhenko AT; Komissarov IV; Serdiuk SE
    Farmakol Toksikol; 1983; 46(1):20-3. PubMed ID: 6297962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
    Raiteri M; Bonanno G; Fedele E
    J Pharmacol Exp Ther; 1989 Aug; 250(2):648-53. PubMed ID: 2547942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group-selective reagent modification of the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex reveals that low-affinity gamma-aminobutyric acid receptors stimulate benzodiazepine binding.
    Burch TP; Thyagarajan R; Ticku MK
    Mol Pharmacol; 1983 Jan; 23(1):52-9. PubMed ID: 6306426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of presynaptic components (uptake--release) in antidepressants].
    Dolzhenko AT
    Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Carboline binding to deoxycholate solubilized benzodiazepine receptors from calf cerebral cortex.
    Sherman-Gold R; Dudai Y
    Neurosci Lett; 1981 Nov; 26(3):325-8. PubMed ID: 6895661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The correlation of the serotonin-positive and anxiolytic activities of nonbenzodiazepine substances].
    Abramets II; Dolzhenko AT; Komissarov IV; Samoĭlovich IM; Talalaenko AN; Kharin NA
    Farmakol Toksikol; 1990; 53(5):13-6. PubMed ID: 1979279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bretylium and guanethidine on 3H-noradrenaline and 3H-serotonin release in rat brain cortex slices.
    Schlicker E; Göthert M
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):196-204. PubMed ID: 6220681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modulatory action of harmane on serotonergic neurotransmission in rat brain.
    Abu Ghazaleh H; Lalies MD; Nutt DJ; Hudson AL
    Brain Res; 2015 Feb; 1597():57-64. PubMed ID: 25498864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models].
    Talalaenko AN; Pankrat'ev DV; Goncharenko NV
    Ross Fiziol Zh Im I M Sechenova; 2001 Sep; 87(9):1217-26. PubMed ID: 11763535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.